Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Heartflow, Inc. Common Stock
HTFL
NASDAQ·Healthcare·Medical - Healthcare Information Services·Mkt cap $2.6B
$27.97
▼ -8.94%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$20.13 - $41.22
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 6.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary AI and computational fluid dynamics technology with strong patent portfolio
- FDA-cleared platform with clinical validation demonstrating superior diagnostic accuracy
- Established relationships with major healthcare systems and integrated delivery networks
- First-mover advantage in functional stenosis assessment for non-invasive coronary imaging
Bear Case
1 risk
- Above-average volatility (beta 1.9).
Growth
Moderate growth ahead
Expanding adoption among interventional cardiologists and cardiac centers globally
Value
Deep value opportunity - significant discount to Healthcare IT & Services peers
Momentum
Hot
+23.7% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying HTFL right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: May 7, 2026
MAY 14, 2026
Reported EPS of -$0.16 vs -$0.18 consensus (+11.1% surprise). Revenue of $52.6M vs $49.7M expected (+5.8%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+11.1%
Next: May 7, 2026
Revenue trend · last 7Q
—
—
+39%
+40%
+72%
+58%
+41%
Q1 24
Q2 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$26.8M
$31.1M
$37.2M
$43.4M
$46.3M
$49.1M
$52.6M
Margins · last 7Q
Gross
—
Operating
—
Profit
-52.1%
Wall Street consensus
4 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
$37.00
▲ +32.3% vs $27.97
Latest: Piper Sandler · Jun 11, 2026
2 analysts covering